SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.34+0.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (15635)2/22/1998 9:50:00 PM
From: RXGOLF  Read Replies (2) of 32384
 
<wtd, NDA applications are really out of my area, but they are not out of LGND's. Unlike most Biotechs, LGND drew almost exclusively from the big Pharmas for senior management (I think that the 1995 Annual Report indicated that senior management had brought over 40 multi-million dollar drugs to market).>

After what happened at DEPO a while back, this now seems very important. What happened to those investors would be hard to swallow, and I can't help but think stronger management might have helped! With the experience that Ligand brings to the table, I would hope that the NDA would come off without incident.

RXGOLF

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext